Documentation Centre

 

 

  of 1550 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study. Am Heart J. 2018;206:80-93 March 26, 2019 Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study. Am Heart J. 2018;206:80-93 Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM Key Publications
Genetic and secondary causes of severe HDL deficiency and cardiovascular disease. J Lipid Res. 2018;59:2421-2435 March 21, 2019 Genetic and secondary causes of severe HDL deficiency and cardiovascular disease. J Lipid Res. 2018;59:2421-2435 Geller AS, Polisecki EY, Diffenderfer MR, Asztalos BF, Karathanasis SK, Hegele RA, Schaefer EJ Key Publications
Long-term consumption of a Mediterranean diet improves postprandial lipemia in patients with type 2 diabetes: the Cordioprev randomized trial. Am J Clin Nutr. 2018;108:963-970 March 19, 2019 Long-term consumption of a Mediterranean diet improves postprandial lipemia in patients with type 2 diabetes: the Cordioprev randomized trial. Am J Clin Nutr. 2018;108:963-970 Gomez-Marin B, Gomez-Delgado F, Lopez-Moreno J, Alcala-Diaz JF, Jimenez-Lucena R, Torres-Peña JD, Garcia-Rios A, Ortiz-Morales AM, Yubero-Serrano EM, Del Mar Malagon M, Lai CQ, Delgado-Lista J, Ordovas JM, Lopez-Miranda J, Perez-Martinez P Key Publications
Among all great studies and papers that you have published, which is your favorite and why? March 13, 2019 Among all great studies and papers that you have published, which is your favorite and why? Marja-Riitta Taskinen, MD, PhD, Emerita Professor of Medicine, Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki University Hospital, Helsinki, Finland Expert Opinions
Video 1:11 min.
(6 MB)
CETP inhibition, statins and diabetes. Atherosclerosis. 2018;278:143-146 March 08, 2019 CETP inhibition, statins and diabetes. Atherosclerosis. 2018;278:143-146 Barter PJ, Cochran BJ, Rye KA Key Publications
Do not forget physical activity and cardiorespiratory fitness. Am J Cardiol. 2018;122:1797-1799 March 01, 2019 Do not forget physical activity and cardiorespiratory fitness. Am J Cardiol. 2018;122:1797-1799 Franklin BA, Kokkinos P, Lavie CJ Key Publications
Lipoprotein(a) is an independent predictor of CVD. Nat Rev Cardiol. 2018;15:727 February 27, 2019 Lipoprotein(a) is an independent predictor of CVD. Nat Rev Cardiol. 2018;15:727 Le Bras A Key Publications
Leptin to adiponectin ratio - A surrogate biomarker for early detection of metabolic disturbances in obesity. Nutr Metab Cardiovasc Dis. 2018;28:1114-1121 February 21, 2019 Leptin to adiponectin ratio - A surrogate biomarker for early detection of metabolic disturbances in obesity. Nutr Metab Cardiovasc Dis. 2018;28:1114-1121 Larsen MA, Isaksen VT, Moen OS, Wilsgaard L, Remijn M, Paulssen EJ, Florholmen J, Goll R. Key Publications
Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases. Nutr Metab Cardiovasc Dis. 2018;28:1100-1105 February 21, 2019 Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases. Nutr Metab Cardiovasc Dis. 2018;28:1100-1105 Schulte DM, Paulsen K, Türk K, Brandt B, Freitag-Wolf S, Hagen I, Zeuner R, Schröder JO, Lieb W, Franke A, Nikolaus S, Mrowietz U, Gerdes S, Schreiber S, Laudes M Key Publications
Metabolism: The road to inflammation and atherosclerosis. Curr Opin Lipidol. 2018;29:474-480 February 15, 2019 Metabolism: The road to inflammation and atherosclerosis. Curr Opin Lipidol. 2018;29:474-480 Ali L, Schnitzler JG, Kroon J Key Publications

  of 1550 Next page

Go to page: of